1.Rac-mediated actin remodeling and myosin II are involved in KATP channel trafficking in pancreatic beta-cells.
Young Eun HAN ; Ajin LIM ; Sun Hyun PARK ; Sunghoe CHANG ; Suk Ho LEE ; Won Kyung HO
Experimental & Molecular Medicine 2015;47(10):e190-
AMP-activated protein kinase (AMPK) is a metabolic sensor activated during metabolic stress and it regulates various enzymes and cellular processes to maintain metabolic homeostasis. We previously reported that activation of AMPK by glucose deprivation (GD) and leptin increases KATP currents by increasing the surface levels of KATP channel proteins in pancreatic beta-cells. Here, we show that the signaling mechanisms that mediate actin cytoskeleton remodeling are closely associated with AMPK-induced KATP channel trafficking. Using F-actin staining with Alexa 633-conjugated phalloidin, we observed that dense cortical actin filaments present in INS-1 cells cultured in 11 mM glucose were disrupted by GD or leptin treatment. These changes were blocked by inhibiting AMPK using compound C or siAMPK and mimicked by activating AMPK using AICAR, indicating that cytoskeletal remodeling induced by GD or leptin was mediated by AMPK signaling. AMPK activation led to the activation of Rac GTPase and the phosphorylation of myosin regulatory light chain (MRLC). AMPK-dependent actin remodeling induced by GD or leptin was abolished by the inhibition of Rac with a Rac inhibitor (NSC23766), siRac1 or siRac2, and by inhibition of myosin II with a myosin ATPase inhibitor (blebbistatin). Immunocytochemistry, surface biotinylation and electrophysiological analyses of KATP channel activity and membrane potentials revealed that AMPK-dependent KATP channel trafficking to the plasma membrane was also inhibited by NSC23766 or blebbistatin. Taken together, these results indicate that AMPK/Rac-dependent cytoskeletal remodeling associated with myosin II motor function promotes the translocation of KATP channels to the plasma membrane in pancreatic beta-cells.
AMP-Activated Protein Kinases/metabolism
;
Actins/*metabolism
;
Animals
;
Cell Line
;
Glucose/metabolism
;
Insulin-Secreting Cells/*metabolism
;
KATP Channels/*metabolism
;
Leptin/metabolism
;
Myosin Type II/*metabolism
;
Phosphorylation
;
Rats
;
*Signal Transduction
;
rac GTP-Binding Proteins/*metabolism
2.Essential Role of Protein Arginine Methyltransferase 1 in Pancreas Development by Regulating Protein Stability of Neurogenin 3
Kanghoon LEE ; Hyunki KIM ; Joonyub LEE ; Chang Myung OH ; Heein SONG ; Hyeongseok KIM ; Seung Hoi KOO ; Junguee LEE ; Ajin LIM ; Hail KIM
Diabetes & Metabolism Journal 2019;43(5):649-658
BACKGROUND: Protein arginine methyltransferase 1 (PRMT1) is a major enzyme responsible for the formation of methylarginine in mammalian cells. Recent studies have revealed that PRMT1 plays important roles in the development of various tissues. However, its role in pancreas development has not yet been elucidated. METHODS: Pancreatic progenitor cell-specific Prmt1 knock-out (Prmt1 PKO) mice were generated and characterized for their metabolic and histological phenotypes and their levels of Neurog3 gene expression and neurogenin 3 (NGN3) protein expression. Protein degradation assays were performed in mPAC cells. RESULTS: Prmt1 PKO mice showed growth retardation and a severely diabetic phenotype. The pancreatic size and β-cell mass were significantly reduced in Prmt1 PKO mice. Proliferation of progenitor cells during the secondary transition was decreased and endocrine cell differentiation was impaired. These defects in pancreas development could be attributed to the sustained expression of NGN3 in progenitor cells. Protein degradation assays in mPAC cells revealed that PRMT1 was required for the rapid degradation of NGN3. CONCLUSION: PRMT1 critically contributes to pancreas development by destabilizing the NGN3 protein.
Animals
;
Diabetes Mellitus
;
Endocrine Cells
;
Gene Expression
;
Islets of Langerhans
;
Mice
;
Pancreas
;
Phenotype
;
Protein Stability
;
Protein-Arginine N-Methyltransferases
;
Proteolysis
;
Stem Cells